The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans - PubMed (original) (raw)
Review
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
Marieke Wichers et al. Int J Neuropsychopharmacol. 2002 Dec.
Free article
Abstract
Administration of the cytokines interferon-alpha and interleukin-2 is used for the treatment of various disorders, such as hepatitis C and various forms of cancer. The most serious side-effects are symptoms associated with depression, including fatigue, increased sleepiness, irritability, loss of appetite as well as cognitive changes. However, great differences exist in the prevalence of the development of depressive symptoms across studies. Differences in doses and duration of therapy may be sources of variation as well as individual differences of patients, such as a history of psychiatric illness. In addition, sensitization effects may contribute to differential responses of patients to the administration of cytokines. In animals administration of pro-inflammatory cytokines induces a pattern of behavioural alterations called 'sickness behaviour' which resembles the vegetative symptoms of depression in humans. Changes in serotonin (5-HT) receptors and in levels of 5-HT and its precursor tryptophan in depressed people support a role for 5-HT in the development of depression. In addition, evidence exists for a dysregulation of the noradrenergic system and a hyperactive hypothalamic-pituitary-adrenal (HPA) axis in depression. Some mechanisms exist which make it possible for cytokines to cross the blood-brain barrier. Pro-inflammatory cytokines such as IL-1beta, IFN-alpha, IFN-gamma and TNF-alpha affect the 5-HT metabolism directly and/or indirectly by stimulating the enzyme indoleamine 2,3-dioxygenase which leads to a peripheral depletion of tryptophan. IL-1, IL-2 and TNF-alpha influence noradrenergic activity and IL-1, IL-6 and TNF-alpha are found to be potent stimulators of the HPA axis. Altogether, administration of cytokines may induce alterations in the brain resembling those found in depressed patients, which leads to the hypothesis that cytokines induce depression by their influence on the 5-HT, noradrenergic and HPA system.
Similar articles
- [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
Vignau J, Karila L, Costisella O, Canva V. Vignau J, et al. Encephale. 2005 May-Jun;31(3):349-57. doi: 10.1016/s0013-7006(05)82400-5. Encephale. 2005. PMID: 16142050 Review. French. - Cytokines and major depression.
Schiepers OJ, Wichers MC, Maes M. Schiepers OJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17. doi: 10.1016/j.pnpbp.2004.11.003. Epub 2005 Jan 25. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15694227 Review. - [Neuropsychiatric symptoms related to interferon alpha].
Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Kiejna A. Małyszczak K, et al. Psychiatr Pol. 2006 Jul-Aug;40(4):787-97. Psychiatr Pol. 2006. PMID: 17068950 Review. Polish. - Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH. Capuron L, et al. Am J Psychiatry. 2003 Jul;160(7):1342-5. doi: 10.1176/appi.ajp.160.7.1342. Am J Psychiatry. 2003. PMID: 12832253 Clinical Trial. - Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.
Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M. Bonaccorso S, et al. J Clin Psychopharmacol. 2002 Feb;22(1):86-90. doi: 10.1097/00004714-200202000-00014. J Clin Psychopharmacol. 2002. PMID: 11799348 Clinical Trial.
Cited by
- Vanillic Acid Protects PC12 Cells from Corticosterone-Induced Neurotoxicity via Regulating Immune and Metabolic Dysregulation Based on Computational Metabolomics.
Lv T, Xue D, Wang P, Gong W, Wang K. Lv T, et al. ACS Omega. 2024 Sep 23;9(39):40456-40467. doi: 10.1021/acsomega.4c03050. eCollection 2024 Oct 1. ACS Omega. 2024. PMID: 39372012 Free PMC article. - Regional neuroinflammation induced by peripheral infection contributes to fatigue-like symptoms: a [18F]DPA-714 positron emission tomography study in rats.
Li D, Hu D, Ochi Y, Arakaki W, Mawatari A, Shigeta M, Wu Y, Hayashinaka E, Neyama H, Tahara T, Wada Y, Li F, Doi H, Watanabe Y, Cui Y. Li D, et al. Front Immunol. 2023 Nov 9;14:1261256. doi: 10.3389/fimmu.2023.1261256. eCollection 2023. Front Immunol. 2023. PMID: 38022622 Free PMC article. - A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.
Banushi B, Polito V. Banushi B, et al. Biology (Basel). 2023 Oct 28;12(11):1380. doi: 10.3390/biology12111380. Biology (Basel). 2023. PMID: 37997979 Free PMC article. Review. - Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.
Nayem J, Sarker R, Roknuzzaman ASM, Qusar MMAS, Raihan SZ, Islam MR, Mahmud ZA. Nayem J, et al. PLoS One. 2023 Nov 15;18(11):e0294288. doi: 10.1371/journal.pone.0294288. eCollection 2023. PLoS One. 2023. PMID: 37967104 Free PMC article. - Elevated Serum IL-2 Levels are Associated With Major Depressive Disorder: A Case-Control Study.
Suhee FI, Shahriar M, Islam SMA, Bhuiyan MA, Islam MR. Suhee FI, et al. Clin Pathol. 2023 Jun 15;16:2632010X231180797. doi: 10.1177/2632010X231180797. eCollection 2023 Jan-Dec. Clin Pathol. 2023. PMID: 37360518 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources